Andrew Ashe

Andrew Ashe

President chez VERVE THERAPEUTICS, INC.

Fortune : 4 M $ au 31/03/2024

57 ans
Health Technology
Commercial Services
Consumer Services

Profil

Andrew D.
Ashe
is currently the President, COO & General Counsel at Verve Therapeutics, Inc. Prior to his current position, he held the role of General Counsel at Beacon Therapeutics (USA), Inc. from 2017 to 2018.
Before that, he served as Secretary, Executive VP & General Counsel at Dyax Corp.
from 2015 to 2016.
Additionally, Mr. Ashe was a Member-Business Law Practices at Nutter McClennen & Fish LLP and Prince Lobel Tye LLP.
He obtained his undergraduate degree from the University of Massachusetts and his graduate degree from George Washington University Law School.
He also holds an undergraduate degree from The Isenberg School of Management.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
14/02/2024 266 509 ( 0,34% ) 4 M $ 31/03/2024

Postes actifs de Andrew Ashe

Anciens postes connus de Andrew Ashe

SociétésPosteFin
APPLIED GENETIC TECHNOLOGIES CORPORATION General Counsel 01/08/2018
DYAX CORP. Chief Administrative Officer 01/01/2016
Corporate Officer/Principal -
Corporate Officer/Principal -
Voir l'expérience en détail de Andrew Ashe

Formation de Andrew Ashe

The Isenberg School of Management Undergraduate Degree
George Washington University Law School Graduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Andrew Ashe

Relations

59

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
VERVE THERAPEUTICS, INC.

Health Technology

Entreprise privées4

Health Technology

Commercial Services

Health Technology

Commercial Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Andrew Ashe